Biotime-Nasdaq's best kept secret? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotime-Nasdaq's best kept secret?

BTIM 0.0001000

0.0%

Nov 5 1:26 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ron Kline who wrote (820)	4/7/1998 2:33:00 PM
From: John L.	Read Replies (1) of 1432

Has there been any word on deals in Asia or Europe to market Hextend? It would be reassuring to hear that companies are interested in making a deal for marketing rights overseas. Abbott was supposed to help BTIM in there application with the FDA, but a 6-12 month evaluation timetable seems to be the next step for Hextend. This is still a long term investment if we are waiting to see profits as a result of product sales. I was personally hoping for some upside movement after the NDA filing, that isn't happening unfortunatly. I am long and will wait another 12 months hoping for the profits to start rolling in. There seems to be good upside potential with minimal downside risk, insiders don't seem to be abandoning ship yet. I hope in a year looking back that that going long will have been the right decision.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next